Pan Coating and Scale-Up: a Practical Guide Based on First Principles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pan Coating and Scale-Up: a Practical Guide Based on First Principles
There are various theories about how to scale up a solid dosage coating operation in a pan coater. This article provides a basic process understanding and scale-up theory based on first principles.


Pharmaceutical Technology Europe


Scaling up the coating process

Various articles on scale-up principles have been published (1–3). The following are basic scale-up principles that can be applied easily in practice:

  • Batch size scale-up is largely dependent on the pan size. As a general rule, the bed depth in proportion to the pan depth should be kept constant. This proportion will help to achieve consistent tablet flow in the scale-up batch, assuming the pans have similar dimensions. However, the technique can also be useful even if the pans are not geometrically similar.
  • Pan RPM scale-up is based on the industry's accepted principle of using the linear distance travelled by tablets in the pan per unit time as constant, and can be applied to obtain similar dynamic conditions during scale-up. The linear distance is calculated as πD, where D is the pan diameter. Using this principle, the following calculation will provide the pan RPM:



  • Air flow scale-up. Air flow is frequently limited by the particular equipment and/or blowers installed on the system. It is important—particularly for functional coatings—to keep the drying kinetics constant as the process is scaled up. This action can be accomplished in accordance with the spray rate scale-up presented below.
  • Spray rate scale-up needs to be in step with air flow scale-up. The coordination should be based on more than the batch size increase because equipment that provides a five-fold batch size increase may only allow a two-fold increase in process air. As a general rule, product temperature should be constant across scales. It's often possible to increase the temperature to allow for higher spray rate during scale-up, but this increase depends on the sensitivity of the coating material, or polymer, and its film-forming properties.

The general principles described above underpin the tablet coating process and can support successful scale-up.

Abhishek Kathuria is technical manager at Evonik Pharma Polymers.

References

1. R. Turton and X.X. Cheng, Powder Technology, 150, 78–85 (2005).

2. S.C. Porter, "Scale-up of film coating", Pharmaceutical Process Scale-Up, M. Levin, Ed., (Marcel Dekker Inc, New York, USA, 2000), pp. 259–310.

3. G.B. Tatterson, Scaleup and Design of Industrial Mixing Processes (McGraw Hill, New York, USA, 1994.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology Europe,
Click here